Harvard Bioscience Inc. (NASDAQ: HBIO) announced that its board of directors approved a 1-for-10 reverse stock split of the company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE